Boston Scientific Broadens Interventional Radiology Reach
This article was originally published in The Gray Sheet
Executive Summary
The firm is acquiring the interventional radiology portfolio of CeloNova Biosciences for $70 million plus milestones, gaining three new microsphere technologies to compete against more established players in the space.